Notice of NIAMS Withdrawal from Participation in PA-18-286 "Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)"

---

Notice Number: NOT-AR-18-018

Key Dates
Release Date: March 6, 2018

Related Announcements
PA-18-286

Issued by
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Purpose

The purpose of this Notice is to inform potential applicants that, effective immediately, NIAMS will no longer participate in PA-18-286 'Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional).'

Currently reads:

Components of Participating Organizations

National Cancer Institute (NCI)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
National Institute on Drug Abuse (NIDA)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Catalog of Federal Domestic Assistance (CFDA) Number(s)

93.865; 93.399; 93.396; 93.395; 93.394; 93.393; 93.279; 93.846

Modified to read:

Components of Participating Organizations

National Cancer Institute (NCI)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
National Institute on Drug Abuse (NIDA)

Catalog of Federal Domestic Assistance (CFDA) Number(s

93.865; 93.399; 93.396; 93.395; 93.394; 93.393; 93.279

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Gayle Lester, Ph.D.
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Telephone: 301 594-3511
Email: lester1@mail.nih.gov

---

Weekly TOC for this Announcement
NIH Funding Opportunities and Notices

---